Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

<< Previous

Bullboard Posts

Next >>

Post by mercedesmanon Apr 21, 2023 9:20pm

339 Views

Post# 35408351

Up 5% !

On heavy ( for Spectral) volume ! Lol

How to get more eyeballs? Especially US ones.

This merits a repost/reminder :

Here's what I know. Baxter has a deal with Spectral most of which is redacted. Baxter recently determined to make a direct investment into Spectral. Baxter also recently announced a reorganization with KidneyCo - a $5 billion spinoff - which prominently featured the EAA and PMX amongst just a few products. Launch is 12 to 18 months which is January 2024 to July 2024. -AP

thx AP ...some of us had forgotten Those important Baxter facts .

BTW Baxter had a nice day on 11 million shares traded.

MM

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal